NCT01492517

Brief Summary

Purpose: The purpose of this protocol is to compare the genetic and epigenetic effects between diesel exhaust and ozone exposure in healthy individuals and in mild/moderate asthmatics. Participants: The investigators will recruit up to 30 mild to moderate asthmatics and up to 50 healthy adults to participate in this study. Procedures (methods): Subjects will be exposed to clean air, to 300 µg/m3 of diesel exhaust for 2 hours and to 0.3 ppm of ozone for 2 hours with intermittent exercise in a controlled environment chamber. Primary endpoints will include spirometry and lung cell changes post-exposure. Secondary endpoints will include analysis of blood clotting/coagulation factors, Holter monitoring of cardiac parameters, analysis of soluble factors present in plasma and bronchial lavage and analysis of intracellular factors present in lung tissue obtained from a brush biopsy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2010

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2010

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

December 13, 2011

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 15, 2011

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2013

Completed
1.9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2015

Completed
Last Updated

January 18, 2016

Status Verified

February 1, 2015

Enrollment Period

3.1 years

First QC Date

December 13, 2011

Last Update Submit

January 15, 2016

Conditions

Keywords

Controlled Human exposure studyAir PollutionGene expressionEpigeneticCardiovascular

Outcome Measures

Primary Outcomes (1)

  • Airway responses

    Airway responses include spirometry and lung cell changes following exposure to either clean air, ozone or diesel exhaust Lung cell changes include change in number and type of cells, changes in genetic (gene expression) and epigenetic responses (primarily changes in DNA methylation, microRNA expression and chromatin modification.

    Pre exposure to 24hours post exposure

Secondary Outcomes (2)

  • Cardiovascular responses

    Pre exposure to 24hours post exposure

  • Soluble factors

    Pre exposure to 24hours post exposure

Study Arms (4)

Clean air exposure

SHAM COMPARATOR

Exposure to clean air will be conducted in an exposure chamber at the EPA Human Studies Facility on the UNC campus. Each subject will be exposed to clean air for 2 hours. Subjects will begin exercising on an exercise bike. Each exercise session will consist of a 15 minute exercise interval at a level of up to 25 L/m2/BSA followed by a 15 minute rest period. The exposure atmosphere will be at approximately 40 + 10% RH and approximately 22 + 2 oC.

Other: Clean Air

Ozone exposure

OTHER

Exposure to 0.3ppm ozone will be conducted in an exposure chamber at the EPA Human Studies Facility on the UNC campus. Each subject will be exposed for 2 hours. Subjects will begin exercising on an exercise bike. Each exercise session will consist of a 15 minute exercise interval at a level of up to 25 L/m2/BSA followed by a 15 minute rest period. The exposure atmosphere will be at approximately 40 + 10% RH and approximately 22 + 2 oC. Ozone exposures will be conducted in a (6 ft x 6 ft x 8 ft) stainless steel chamber with a continuous supply of exposure medium. Ozone will be monitored continuously.

Other: Ozone exposure

Diesel exhaust exposure

OTHER

Exposure to diesel exhaust will be conducted in an exposure chamber at the EPA Human Studies Facility on the UNC campus. Each subject will be exposed to diesel exhaust (up to 300 ug/m3). Subjects will begin exercising on an exercise bike. Each exercise session will consist of a 15 minute exercise interval at a level of up to 25 L/m2/BSA followed by a 15 minute rest period. The exposure atmosphere will be at approximately 40 + 10% RH and approximately 22 + 2 oC. The DE will be generated from a diesel generator used to power a load bank that is located outside the Human Studies Facility, and subsequently introduced into the exposure chamber after different dilutions with clean HEPA and charcoal filtered and humidified air to give a chamber concentration of up to 300 μg/m3.

Other: Diesel exhaust

18Ozone

OTHER

Exposure to ozone generated using the heavy non-radioactive isotope of oxygen (18O). Exposure to 0.3ppm 18O will be conducted in an exposure chamber at the EPA Human Studies Facility on the UNC campus. Each subject will be exposed for 2 hours. Subjects will begin exercising on an exercise bike. Each exercise session will consist of a 15 minute exercise interval at a level of up to 25 L/m2/BSA followed by a 15 minute rest period. The exposure atmosphere will be at approximately 40 + 10% RH and approximately 22 + 2 oC. Ozone exposures will be conducted in a (6 ft x 6 ft x 8 ft) stainless steel chamber with a continuous supply of exposure medium. Ozone will be monitored continuously.

Other: Ozone18

Interventions

Exposure to 0.3ppm ozone for 2 hours

Also known as: O3
Ozone exposure

Diesel exhaust generated from a diesel generator delivered to the exposure at a target concentration of 300 μg/m3

Also known as: DE, DEP
Diesel exhaust exposure
Ozone18OTHER

Exposure to ozone generated using the heavy non-radioactive isotope of oxygen (18O).

Also known as: O18
18Ozone

Exposure to air which has been scrubbed to remove air pollutants including ozone and particles.

Also known as: CA
Clean air exposure

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Physical exams will be performed by study physicians during the screening visit (IRB approved EPA protocol 95-EPA-66).
  • Normal lung function (pre or post albuterol), defined by Knudson 1976/1984 as:
  • \- FVC of \> 75 % of that predicted for gender, ethnicity, age and height.
  • \- FEV1 of \> 75 % of that predicted for gender, ethnicity, age and height.
  • \- FEV1/FVC ratio of \> 75 % of predicted values.
  • Oxygen saturation of \> 96 %.
  • Ability to tolerate intervals of moderate exercise
  • Mild to Moderate Asthmatics
  • Physical exams will be performed by study physicians during the screening visit (IRB approved EPA protocol 95-EPA-66) where diagnosis will be judged by EPA physicians.
  • Mild/Moderate asthmatics as defined by NHLBI guidelines.
  • Positive history of asthma (wheezing, chest tightness, and reversible airway obstruction);
  • Baseline FEV1/FVC ≥ 60%;
  • Oxygen saturation of ≥ 94%
  • Ability to tolerate moderate exercise

You may not qualify if:

  • Healthy Individuals
  • A history of chronic illnesses such as diabetes, rheumatological diseases, immunodeficiency state, known clinically significant cardiac disease (including myocardial infarction, congestive heart failure and angina), chronic respiratory diseases such as chronic obstructive pulmonary disease, and lung cancer.
  • If the subject is pregnant, attempting to become pregnant or breastfeeding.
  • Allergy to any medications which may be used or prescribed in the course of this study.
  • Smoking history within 2 years of the study.
  • Use of inhaled steroids, cromolyn, or leukotriene inhibitors (Montelukast, Zafirkulast, etc) initiated within the past month (except for use of cromolyn exclusively prior to exercise). Patients must be on a stable regimen of therapy.
  • Untreated hypertension (\> 150 systolic, \> 90 diastolic)
  • Dementia.
  • History of skin allergy to tape or electrodes.
  • Subjects who do not understand or speak English
  • Subjects who are unable to perform moderate exercise
  • <!-- -->
  • Any food or fluids after midnight prior to bronchoscopy
  • FEV1/FVC ratio less than 60% predicted on AM of bronchoscopy.
  • Regular use of aspirin or other nonsteroidal anti-inflammatory drugs (which inhibit platelet function).
  • +10 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

U.S. EPA Human Studies Facility

Chapel Hill, North Carolina, 27514, United States

Location

Related Publications (3)

  • Sommer AJ, Okonkwo J, Monteiro J, Bind MC. A permutation-based approach using a rank-based statistic to identify sex differences in epigenetics. Sci Rep. 2023 Sep 8;13(1):14838. doi: 10.1038/s41598-023-41360-6.

  • Miller DB, Ghio AJ, Karoly ED, Bell LN, Snow SJ, Madden MC, Soukup J, Cascio WE, Gilmour MI, Kodavanti UP. Ozone Exposure Increases Circulating Stress Hormones and Lipid Metabolites in Humans. Am J Respir Crit Care Med. 2016 Jun 15;193(12):1382-91. doi: 10.1164/rccm.201508-1599OC.

  • Devlin RB, Duncan KE, Jardim M, Schmitt MT, Rappold AG, Diaz-Sanchez D. Controlled exposure of healthy young volunteers to ozone causes cardiovascular effects. Circulation. 2012 Jul 3;126(1):104-11. doi: 10.1161/CIRCULATIONAHA.112.094359. Epub 2012 Jun 25.

MeSH Terms

Interventions

Vehicle Emissions1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochlorideEnvironment, Controlled

Intervention Hierarchy (Ancestors)

Complex MixturesEnvironmentEnvironment and Public Health

Study Officials

  • David Diaz-Sanchez, Ph.D.

    U.S. Environmental Protection Agency

    STUDY DIRECTOR
  • Kelly Duncan, PhD

    University of North Carolina, Chapel Hill

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Intervention Model
CROSSOVER
Sponsor Type
FED
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief, Clinical Research Branch

Study Record Dates

First Submitted

December 13, 2011

First Posted

December 15, 2011

Study Start

May 1, 2010

Primary Completion

June 1, 2013

Study Completion

May 1, 2015

Last Updated

January 18, 2016

Record last verified: 2015-02

Locations